AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

List of Certara D360 Customers

loading spinner icon



Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Agios Pharmaceuticals Life Sciences 536 $125M United States Certara Certara D360 Laboratory Management 2014 n/a
In 2014, Agios Pharmaceuticals implemented Certara D360 as a Laboratory Management application to support discovery and preclinical research functions. Agios Pharmaceuticals using Certara D360 as Laboratory Management provided scientists with on demand access to drug discovery and development data across studies, enabling query, analysis, and visualization workflows without constant IT support. Certara D360 was configured to provide integrated query, analysis, and visualization capabilities, with searchable cross study data views and access to historical control data that are typical requirements for preclinical research. The Certara D360 implementation emphasized self service data access for bench scientists, reducing the need for manual review of multiple study reports and streamlining scientific decision making in discovery and preclinical groups. Operational coverage centered on discovery and preclinical research departments, where Certara D360 enabled rapid assembly of cross study evidence to answer regulatory questions. The deployment supported scientists in generating on demand reports and visualizations to respond to regulatory agencies, shortening the time required to retrieve cross study information and avoiding costly delays in approval processes. Governance and workflow changes focused on shifting manual report collation into governed, on demand data queries and standardized analysis workflows. By embedding Certara D360 into lab operations, Agios Pharmaceuticals formalized data access controls and analytic patterns used by research teams, improving the consistency of responses to regulatory inquiries and accelerating go no go decisions in early development.
Arvinas Life Sciences 280 $46M United States Certara Certara D360 Laboratory Management 2020 n/a
In 2020, Arvinas implemented Certara D360 as a Laboratory Management solution to advance the speed and efficiency of discovery research. The deployment targeted discovery research workflows, consolidating study data and operational processes used by bench scientists and research project teams within the organization. Certara D360 was configured to deliver category-aligned capabilities including assay workflow orchestration, sample and inventory tracking, study data capture and management, and role based data access for research governance. The implementation focused on standardizing laboratory workflows and centralizing discovery data to support reproducible study execution, while aligning electronic lab procedures and access controls with research governance needs.
AstraZeneca US Life Sciences 17535 $17.7B United States Certara Certara D360 Laboratory Management 2014 n/a
In 2014, AstraZeneca US implemented Certara D360 as a Laboratory Management application to consolidate laboratory and assay informatics workflows across R&D functions. The Certara D360 deployment was positioned to support discovery chemistry, DMPK assay handling, and clinical study data capture used by clinical study teams and site selection and monitoring analysis groups. The implementation emphasized laboratory data management capabilities, including standardized assay and chemistry data capture, metadata management for study and protocol elements, and support for master data entity catalog efforts that documented entities, data types, affiliated systems and FAIR status. Configuration work focused on instrument and assay result onboarding, assay metadata templates, and role based access for bench scientists and informatics users. Operational integration linked Certara D360 into AstraZeneca US informatics and analytics tooling, operating alongside visualization and analytics tools such as SpotFire and Pipeline Pilot, ETL pipelines built with Informatica PowerCenter, and site data held in Oracle databases and in-house applications including Activity Base and Assay Explorer. Backend architecture work included designing connectors and processes to incorporate study data from external sources and to feed downstream analytics and reporting systems. Governance and adoption activities included targeted training for scientists on Certara D360, process optimization exercises with DMPK teams to standardize workflows, and the creation of documented business processes and validated system artifacts to support regulated R&D use. The rollout prioritized harmonized data capture for site feasibility and patient recruitment estimates, and local informatics teams coordinated configuration and user enablement across discovery and clinical groups.
Life Sciences 11 $3M United States Certara Certara D360 Laboratory Management 2020 n/a
Life Sciences 54500 $28.9B Germany Certara Certara D360 Laboratory Management 2013 n/a
Life Sciences 13248 $14.4B United States Certara Certara D360 Laboratory Management 2013 n/a
Life Sciences 2500 $1.1B United States Certara Certara D360 Laboratory Management 2015 n/a
Healthcare 2400 $600M United States Certara Certara D360 Laboratory Management 2022 n/a
Life Sciences 6000 $1.5B Denmark Certara Certara D360 Laboratory Management 2020 n/a
Life Sciences 120 $10M United States Certara Certara D360 Laboratory Management 2020 n/a
Showing 1 to 10 of 17 entries

Buyer Intent: Companies Evaluating Certara D360

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Certara D360. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Certara D360 for Laboratory Management include:

  1. Astorg, a Luxembourg based Banking and Financial Services organization with 170 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Certara D360 Coverage

Certara D360 is a Laboratory Management solution from Certara.

Companies worldwide use Certara D360, from small firms to large enterprises across 21+ industries.

Organizations such as Pfizer, Boehringer Ingelheim, AstraZeneca US, Boehringer Ingelheim USA and Takeda Pharmaceuticals USA are recorded users of Certara D360 for Laboratory Management.

Companies using Certara D360 are most concentrated in Life Sciences and Manufacturing, with adoption spanning over 21 industries.

Companies using Certara D360 are most concentrated in United States and Germany, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Certara D360 across Americas, EMEA, and APAC.

Companies using Certara D360 range from small businesses with 0-100 employees - 17.65%, to mid-sized firms with 101-1,000 employees - 35.29%, large organizations with 1,001-10,000 employees - 17.65%, and global enterprises with 10,000+ employees - 29.41%.

Customers of Certara D360 include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Certara D360 customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.